Leerink Partners Remains a Buy on Hologic (HOLX)
Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report) yesterday and set a price target of $80.00.
Hologic’s Resilience in Diagnostics Supports Buy Rating Amidst Mixed Segment Performance
Leerink Partners analyst Puneet Souda has maintained their bullish stance on HOLX stock, giving a Buy rating on January 13.Stay Ahead of the ...
American Association of Individual Investors24 天
Which Is a Better Investment, Hologic, Inc. or Insulet Corporation Stock?
In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; ...
American Association of Individual Investors1 个月
Which Is a Better Investment, Baxter International Inc. or Hologic, Inc. Stock?
In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; ...